Immunocore's Grant - II Round

Immunocore raised a round of funding on September 18, 2017. Investors include Bill & Melinda Gates Foundation.

Immunocore is a biotechnology company, with a highly innovative immuno-oncology platform technology called ImmTACs. ImmTACs are a novel class of biologic drugs based on the Company's proprietary T cel…

Articles about Immunocore's Grant - II Round: